abirateron polisano 500 mg filmtabletten
abirateron polisano 250 mg filmtabletten
mexiprim 50mg/ml solution for i/m and i/v injection
scientific technological pharmaceutical firm polisan llc - ethylmethylhydroxypyridine succinate - solution for i/m and i/v injection - 50mg/ml
mexiprim 50mg/ml solution for i/m and i/v injection
scientific technological pharmaceutical firm polisan llc - ethylmethylhydroxypyridine succinate - solution for i/m and i/v injection - 50mg/ml
cycloferon solution for i/m and i/v injection
scientific technological pharmaceutical firm "polisan" ltd - acridonacetic acid, n-methyl glucamin (meglumin) - solution for i/m and i/v injection - 125mg/ml+ 96,3mg/ml
mexiprim solution for i/m and i/v injection
scientific technological pharmaceutical firm polisan llc - ethylmethylhydroxypyridine succinate - solution for i/m and i/v injection - 50mg/ml (10/2x5/) ampoules 2ml in blister
mexiprim solution for i/m and i/v injection
scientific technological pharmaceutical firm polisan llc - ethylmethylhydroxypyridine succinate - solution for i/m and i/v injection - 50mg/ml (5/1x5/) ampoules 5ml in blister
mexiprim solution for i/m and i/v injection
scientific technological pharmaceutical firm polisan llc - ethylmethylhydroxypyridine succinate - solution for i/m and i/v injection - 50mg/ml
mexiprim solution for i/m and i/v injection
scientific technological pharmaceutical firm polisan llc - ethylmethylhydroxypyridine succinate - solution for i/m and i/v injection - 50mg/ml
imatinib clonmel 100 mg film-coated tablets
clonmel healthcare ltd - imatinib - film-coated tablet - 100 milligram(s) - other antineoplastic agents - antineoplastic agents, protein kinase inhibitor - imatinib clonmel is indicated in: paediatric patients with newly diagnosed philadelphia chromosome (bcr-abl) positive (ph+) chronic myeloid leukaemia (cml) for whom bone marrow transplantation is not considered as the first line of treatment. paediatric patients with ph+ cml in chronic phase after failure of interferon-alpha therapy, or in accelerated phase or blast crisis. adult patients with ph+ cml in blast crisis adult patients with newly diagnosed philadelphia chromosome positive acute lymphoblastic leukaemia (ph+ all) integrated with chemotherapy. adult patients with relapsed or refractory ph+ all as monotherapy. adult patients with myelodysplastic/myeloproliferative diseases (mds/mpd) associated with platelet-derived growth factor receptor (pdgfr) gene re-arrangements. adult patients with advanced hypereosino